Umoja Biopharma Announces Appointment of Britton Russell as
SEATTLE,, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc., (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that...
Source: globenewswire.com
Jason Braco News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jason Braco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jason Braco Today - Breaking & Trending Today
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
MeiraGTx to receive $50 million milestone after initiation of the extension study for the Phase 3 LUMEOS clinical trial for botaretigene sparoparvovec for the treatment of X-linked retinitis...
Source: marketscreener.com
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
- Conference Call and Webcast Today, February 6, 2024, at 4:30 p.m. ETPASADENA, Calif.--(BUSINESS WIRE)--$arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 first quarter ended December 31, 2023. The Company is hosting a conference call today, February 6, 2024,...
Source: pharmiweb.com
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Omega collaboration will leverage the company’s platform to develop an epigenomic controller as part of a new approach to obesity managementCellarity collaboration will build upon initial work and...
Source: marketscreener.com
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
- MeiraGTx enters into an Asset Purchase Agreement related to botaretigene sparoparvovec for the treatment of X-linked retinitis pigmentosa for a total of up to $415 million - MeiraGTx to receive...
Source: marketscreener.com